Our findings suggest that carnitine can couple mechanical stimulation and fatty acid metabolism to influence muscle cell fate; mechanical interventions as well as the targeting of OCTN2 to increase the carnitine content may be therapeutic approaches for preventing sarcopenia. The gene discussed is SLC22A5; the disease is sarcopenia.